• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • About Us
  • Our Laboratory
  • Contact Us
NPS Discovery
  • Reports
    • NPS Discovery Dashboard
    • Monographs
    • Trend Reports
    • Public Alerts
    • NPS Scope Recommendations
    • Drug Checking
    • Clinical Reports
    • NPS Discovery Toolkits
  • Resources
    • Publications
    • Presentations
    • Helpful Links
    • NPS in the News
  • CFSRE
Home Drug Checking Drug Checking Report (Q1 2022): Philadelphia, Pennsylvania, USA

Drug Checking Report (Q1 2022): Philadelphia, Pennsylvania, USA

March 22, 2022

A partnership between the Center for Forensic Science Research and Education (CFSRE) and the Philadelphia Department of Public Health (PDPH) has been established to accurately assess the drug supply in Philadelphia, Pennsylvania. This initiative was established as a comprehensive effort. Select drug testing results from samples obtained within the city were compiled for preparation of this report. The results reported herein may not represent the entirety of the drug supply. The Drug Checking Report is intended to help promote timely and appropriate public health and public safety preparedness and response.

Summary and Key Findings:
▪ 36 samples were reported between January and February 2022
▪ Most “heroin” samples contained fentanyl cut with xylazine
▪ Fentanyl combinations with methamphetamine and cocaine were observed in this sample set, however, not commonly
▪ Cocaine samples were not adulterated in this sample set*
▪ para-Fluorofentanyl continues increasing in prevalence, being identified as the primary opioid in some “heroin” samples
▪ A counterfeit tablet was found to contain an NPS benzodiazepine

CLICK HERE TO ACCESS THE DRUG CHECKING REPORT

Tags: Assessment, Drug, Drug Checking, Drug Material, Fentanyl, Heroin, NPS, Opioids, philadelphia, Public Health, Raw Material, Seized Drug, Supply

Reader Interactions

sidebar

Popular Tags

  • Toxic
  • NPS
  • Synthetic
  • drugs
  • Toxicology
  • Emergency Department
  • Synthetic Opioid
  • Drug
  • Adulterant
  • overdose
  • philadelphia
  • Chemistry
  • Clinical
  • Forensic
  • Public Health
  • Heroin
  • Fentanyl
  • Postmortem
  • Opioids
  • opioid

Meet Our Scientists

Alex J. Krotulski, PhD
Associate Director & Program Manager

Mandi L.A. Mohr, MSFS, D-ABFT-FT
Associate Director

Melissa F. Fogarty, MSFS, D-ABFT-FT
Laboratory Manager

Sara E. Walton, BS
Forensic Science Technician

Barry K. Logan, PhD, F-ABFT
Executive Director

Email Us At

npsdiscovery@cfsre.org

Contact Us

  • npsdiscovery@frfoundation.org
  • 215-366-1591

About Us

Newsroom

Follow Us


© 2022 The Center for Forensic Science Research & Education
  • Privacy Policy
  • Terms of Use
  • Sitemap